Agenus Says FDA Advised Against Accelerated Approval for Potential Colorectal Cancer Treatment; Shares Tumble
Agenus Says FDA Advised Against Accelerated Approval for Potential Colorectal Cancer Treatment; Shares Tumble
艾吉纳斯表示FDA建议不要对潜在的结直肠癌治疗进行加速批准;股价下跌
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册